For years, doctors at the Queen Elizabeth Hospital quietly waited for this moment. Without legislation, Barbados could not run a cadaveric organ donation programme. Tissue typing samples had to be sent to the United States. Patients with end-stage renal disease whose families had no match — or no living donor — simply ran out of options. Some went to dialysis and stayed there. Some did not survive.

The Human Tissue Transplant Bill, 2023, which is now before the Barbados Senate for its Second Reading, changes that. If passed and properly resourced, it creates the legal framework that allows a deceased-donor programme to begin — potentially enabling up to 48 transplant surgeries per year at QEH alone, according to consultants at the hospital.

This is also a story that crosses party lines. The Democratic Labour Party (DLP) laid the clinical groundwork during its years in office; the Barbados Labour Party (BLP) converted that foundation into formal legislation. Both deserve acknowledgement — and this article gives them both their due. But legislation is not the same as outcomes, and this Bill deserves scrutiny as much as celebration. Here is a clear-eyed look at both.

A story that spans two administrations

Credit for this legislation does not belong to one party alone — and any honest account of this Bill must say so plainly.

It was during the Democratic Labour Party (DLP) administration under Prime Minister Freundel Stuart that the clinical groundwork began. Barbados performed its first kidney transplant at the Queen Elizabeth Hospital in 2015 — a milestone achieved while the DLP held office. The push from QEH’s medical team to expand beyond living donors and establish a legislative framework also began taking shape during those years, even if no Bill was formally tabled. The DLP government’s tenure (2008–2018) saw the transplant programme move from concept to clinical reality, however limited in scope.

When the Barbados Labour Party (BLP) under Prime Minister Mia Mottley swept into office in 2018, the medical advocacy was already in motion. By November 2020, QEH’s Chief Executive and lead transplant nephrologist were publicly calling for legislation, describing a Bill as “almost ready for introduction to Parliament.” It took a further three years, but in September 2023 — in the BLP’s second term — the Human Tissue Transplant Bill, 2023 was formally introduced into the House of Assembly and subsequently passed. It now sits before the Senate.

This is a cross-party story: one administration built the clinical foundation, the other converted it into law. Both deserve to be part of the record. Barbados Policy Pulse states this not as political balance for its own sake, but because the truth of how policy actually moves — slowly, across electoral cycles, driven as much by clinicians as by politicians — is precisely what this publication exists to document.

What the Bill actually does

At its core, the Bill establishes the legal conditions under which tissue — including organs such as kidneys, livers, bone marrow, and corneas — can be removed from one person (living or deceased) and transplanted into another. It creates a National Transplantation Council, defines who can consent and how, and places firm prohibitions on the commercial trade in human tissue.

The Bill applies to all persons in Barbados, regardless of nationality or residency status — which means it directly affects returning members of the diaspora.

The consent question — and why it matters here

Some jurisdictions have moved toward what is called “presumed consent” or opt-out donation, where the state assumes you agree to donate unless you have formally registered an objection. This Bill does not do that — and that is the right call for Barbados.

Research on Barbadian attitudes to organ donation found that the most significant barrier was not religion — most respondents had no doctrinal objection to donation — but trust in the medical system. Specifically, people worried that a doctor might not try as hard to save a patient they knew had agreed to donate. That concern is human, understandable, and requires an answer from the health system, not from the law.

The Bill addresses this directly: the two doctors who certify death cannot be the same doctors who remove or transplant tissue. That separation matters. It should be enforced rigorously and communicated clearly to the public.

For Barbadians who have lived abroad — particularly in the UK, Canada, or the United States, where opt-out systems have been introduced or debated — it is worth knowing that the evidence on presumed consent is more complicated than its advocates suggest. Studies across five countries that switched to opt-out found donation rates did not increase. What did increase rates — in Spain, the world leader with 49.4 donors per million — was dedicated hospital transplant coordinators, national logistics infrastructure, and sustained public trust. The law was almost incidental.

The infrastructure gap nobody is talking about

The QEH’s Chief Executive has been clear: legislation and infrastructure must go together. Right now, Barbados sends tissue typing samples to the United States. Without a local laboratory, the window to match a recently deceased donor to a compatible recipient is dangerously narrow — time that could cost a viable kidney. A law without a funded lab, without trained transplant coordinators embedded at QEH, and without a national donor registry is a framework without a floor.

Parliament should press government for a published implementation plan — with timelines and budgets — before this Bill is proclaimed into force.

A guide for returning Bajans and the diaspora

If you are part of the Barbadian diaspora — whether you are planning to return, already back, or simply maintaining ties with family at home — this Bill has practical implications you need to understand now, while the law is still being shaped.

1. Your donor status from abroad does not transfer

If you were registered as an organ donor in the UK (NHS Organ Donor Register), the United States (your state registry), Canada, or anywhere else, that registration has no legal standing in Barbados. Once this Bill is proclaimed, a new national registration system will need to be established. Watch for its launch and register your wishes explicitly.

2. Your wishes need to be on record — and your family needs to know them

Under this Bill, a designated transplant officer can authorise donation after death if they are satisfied the deceased consented — or if the next of kin consents. The strongest protection for your wishes, whether you want to donate or do not, is twofold: a written declaration (which can be included in a will under the Succession Act) and a clear, explicit conversation with your next of kin. Do not assume your family knows how you feel.

3. If you have existing health conditions, understand the system you are returning to

Barbados’s public healthcare is among the best in the Caribbean, but it has real capacity constraints. For diaspora members returning with chronic kidney disease, diabetes-related complications, or conditions that may eventually require a transplant, the passage of this Bill is potentially life-changing — because a deceased-donor programme means your only option is no longer finding a willing living relative.

Register with the polyclinic system immediately upon return. If you have a specialist relationship abroad, request a full medical summary to bring with you. Continuity of care matters, and the QEH transplant unit will need your full history.

4. Private health insurance coverage for transplantation

Public healthcare in Barbados covers transplant procedures at QEH, but private insurance coverage for post-transplant immunosuppressive medication — which patients need for life — varies significantly by policy. If you are taking out private insurance upon return, ask specifically about transplant-related aftercare coverage before signing.

5. For parents — understand the minor provisions

The Bill permits parents or guardians to consent to the removal of regenerative tissue from a child for transplantation into a sibling or parent. If a child has the mental capacity to understand the procedure, they must also consent. If they do not have that capacity, the parent alone can consent with independent medical certification. As a parent returning to Barbados, understand this provision exists and that it applies to your family. It is not sinister — bone marrow donations between siblings, for example, are genuinely life-saving — but you should know your legal position.

What to watch as this Bill moves forward

The Bill will be proclaimed into force by a date set by the Governor-General after Senate passage. Between that passage and the proclamation date, several things need to happen. Here is what Barbados Policy Pulse will be tracking:

• 1Publication of Ministerial Regulations, particularly on tissue allocation criteria. These will determine who gets organs and in what order — arguably the most consequential decisions in the entire framework, and currently absent from the Bill.
• 2Appointment of the National Transplantation Council. Watch whether the bioethicist, NGO representative, and transplant beneficiary seats are filled with genuine independence or political convenience.
• 3Launch of the national donor registry. Without one, the consent-first model has no infrastructure to work with.
• 4Announcement of a tissue typing laboratory at QEH. The hospital has said this is a precondition for a functional deceased-donor programme. It has not been funded in any published budget to date.
• 5A public education campaign. Evidence from comparable systems shows that what families know — and how much they trust — determines donation rates more than the law itself.

The bottom line

This is a Bill Barbados has needed for a long time, and the fundamentals are sound. The consent-first framework respects the religious and cultural reality of a society where community trust is not abstract — it is the currency on which a donation programme will actually run. The anti-trafficking provisions are strong. The oversight architecture, while imperfect, is more independent than many comparable small-state models.

But the real test of this legislation will not be its passage. It will be whether government follows it with the investment in infrastructure, the trained personnel, and the public communication that make the law mean something in practice. Legislation without implementation is a promise without a plan.

For those returning to Barbados — whether from London, Toronto, New York, or Miami — make your wishes known now, understand the system you are re-entering, and stay engaged with what comes next. This Bill will shape healthcare in Barbados for a generation.